about
Pharmacogenetic studies update in type 2 diabetes mellitusPro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes.Sterile leukocyturia affects urine neutrophil gelatinase-associated lipocalin concentration in type 2 diabetic patients.Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM).Is gliclazide a sulfonylurea with difference? A review in 2016.Antiplatelet and anticoagulant therapy in elderly people with type 2 diabetes mellitus in Poland (based on the PolSenior Study).Anti-diabetic drug binding site in a mammalian KATP channel revealed by Cryo-EM.Antidiabetic Effect of Brain-Derived Neurotrophic Factor and Its Association with Inflammation in Type 2 Diabetes Mellitus.Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis.Dual Therapy Appears Superior to Monotherapy for Low-Income Individuals With Newly Diagnosed Type 2 Diabetes.Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study.The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?Loureirin B promotes insulin secretion through inhibition of KATP channel and influx of intracellular calcium.Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.Sulfur-Containing Agrochemicals.Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus - International Task Force.β-aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway.The role of adipokines in skeletal muscle inflammation and insulin sensitivity.Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million PatientsEffects of Three Thiazolidinediones on Metabolic Regulation and Cold-Induced Thermogenesis
P2860
Q26739350-69268B2F-EF06-4EAA-8EE5-EECC95A1DFC7Q30234356-3595F643-B528-4048-81FB-316CA309D487Q37620904-87BB29FD-D72F-49A5-90C6-1733D24F31EEQ37675571-0EEE6B87-6286-455A-B1A4-5C9494AD0469Q38663548-F963229A-7B29-4B89-ABFC-EBF0611C8353Q38754132-14C55763-16C6-4B5A-889B-FFC6C2336002Q41549676-141701E9-F795-41E7-9B05-F6C90EAC35D5Q42637813-512FBA02-F1AF-464A-8227-9592E2CC5D3DQ43373021-1A7D53EB-8B01-496D-9A57-6CF8B801937FQ46686457-D85E00F5-6A12-4237-8BAF-C586378B09CEQ47144635-17445A48-B930-47AF-BB10-ADED5ED88743Q47160310-BC604A62-52D5-44AF-B851-55AA914404DCQ47733021-4A8D1C20-64DA-4227-AF3F-C44FCDA0D532Q47940901-0BEF14EA-7B58-49B1-92DC-BCBBD47C2493Q48177243-A50F9CC2-8EBF-43AB-96D1-CCB7D0782DC8Q49375173-B45F734F-8877-4EF4-99AE-E73D051B7FBDQ50043733-F406B6C2-1C62-4B91-8B70-4C9420C6E2D1Q52657004-997BC768-4D1C-497A-B31C-415ED498A1DEQ53076733-2F5CB505-44EA-4832-9E50-3738C6387441Q53682459-ED762F8C-5F32-4030-84A6-F31E02EE3137Q58698213-27F79BE1-10D0-473F-A35C-E117872F51ADQ58703696-D31D5B4E-3E17-4A5B-A275-5B1DFD37904A
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sulfonylureas and their use in clinical practice.
@en
type
label
Sulfonylureas and their use in clinical practice.
@en
prefLabel
Sulfonylureas and their use in clinical practice.
@en
P2093
P2860
P50
P356
P1476
Sulfonylureas and their use in clinical practice
@en
P2093
Ettore Bartoli
Francesca Corlianò
Gian Paolo Fra
Gian Piero Carnevale Schianca
Luca Rossi
Marcello Bigliocca
Roberto Mella
P2860
P304
P356
10.5114/AOMS.2015.53304
P577
2015-08-11T00:00:00Z